奥氮平及阿立哌唑治疗首发精神分裂症患者的疗效差异及对患者甲状腺激素的影响

Differences in efficacy between olanzapine and aripiprazole in patients with first-episode schizophrenia and their effects on thyroid hormones

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2019, 46(3)
作者
作者单位

河南科技大学第五附属医院精神科女一区 ;

摘要
【摘要】 目的:探究首发精神分裂症患者行奥氮平、阿立哌唑治疗的效果差异及对甲状腺激素的影响。方法:选取2016年1月至2018年9月本院收治的首发精神分裂症患者136例,按随机数表法分为两组,均68例。奥氮平组给予奥氮平片10~20 mg/d治疗,阿立哌唑组给予阿立哌唑片10~30 mg/d治疗,均治疗12周。观察两组临床疗效及治疗前后阳性和阴性症状量表(PANSS)评分、甲状腺激素(T4、T3、TSH、FT3、FT4)水平。结果:两组治疗总有效率(奥氮平组85.29%、阿立哌唑组82.35%)比较差异无统计学意义(P>0.05)。两组治疗后PANSS评分均较治疗前降低(P<0.05),而组间差异无统计学意义(P>0.05)。相比治疗前,奥氮平组治疗后FT4、T3、T4水平降低(P<0.05),TSH升高(P<0.05);阿立哌唑组FT4降低(P<0.05),而FT3、T3、T4、TSH相比治疗前无统计学差异(P>0.05);治疗后两组FT3水平无统计学差异(P>0.05),奥氮平组FT4、T3、T4低于阿立哌唑组,TSH高于阿立哌唑组,差异有统计学意义(P<0.05)。阿立哌唑组不良反应率(11.76%)低于奥氮平组(16.18%),但差异无统计学意义(χ2=0.551,P>0.05)。结论:奥氮平、阿立哌唑对首发精神分裂症治疗效果和安全性均较好,但奥氮平对患者甲状腺激素的影响更显著。
Abstract
【Abstract】 Objective: To investigate the effects of olanzapine and aripiprazole in patients with first-episode schizophrenia and their effects on thyroid hormones. Methods: A total of 136 patients with first-episode schizophrenia admitted to our hospital from January 2016 to September 2018 were enrolled in the study.According to the random number table method, they were divided into two groups, all of which were 68 cases.The olanzapine group was given olanzapine tablets 10~20 mg/d, and the aripiprazole group was given aripiprazole tablets 10~30 mg/d.Treated for 12 weeks.The clinical efficacy and the positive and negative symptom scale (PANSS) scores and thyroid hormones (T4, T3, TSH, FT3, FT4) levels were observed before and after treatment. Results: There was no significant difference in the total effective rate between the two groups (85.29% in the olanzapine group and 82.35% in the aripiprazole group) (P>0.05).The PANSS scores of the two groups were lower than those before treatment (P<0.05), but there was no significant difference between the two groups (P>0.05).Compared with before treatment, the levels of FT4, T3 and T4 were decreased (P<0.05) and TSH was increased after treatment with olanzapine (P<0.05).The FT4 of aripiprazole group was decreased (P<0.05), but there was no significant difference in FT3, T3, T4 and TSH compared with before treatment (P>0.05).There was no significant difference in FT3 levels between the two groups after treatment (P>0.05). FT4, T3 and T4 in the olanzapine group were lower than those in the aripiprazole group, and TSH was higher than the aripiprazole group. The difference was statistically significant (P<0.05).The adverse reaction rate of aripiprazole group (11.76%) was lower than that of olanzapine group (16.18%), but the difference was not statistically significant (χ2=0.551, P>0.05). Conclusion: Olanzapine and aripiprazole have better therapeutic effects and safety for first-episode schizophrenia, but olanzapine has a more significant effect on thyroid hormones.
关键词
【关键词】 首发精神分裂症;奥氮平;阿立哌唑;临床疗效;甲状腺激素
KeyWord
【Key words】 First-episode schizophrenia; Olanzapine; Aripiprazole; Clinical efficacy; Thyroid hormone
基金项目
页码 448-450
  • 参考文献
  • 相关文献
  • 引用本文

王敬巍*. 奥氮平及阿立哌唑治疗首发精神分裂症患者的疗效差异及对患者甲状腺激素的影响 [J]. 国际精神病学杂志. 2019; 46; (3). 448 - 450.

  • 文献评论

相关学者

相关机构